MD HB1112

Expands the duties of the Maryland Health Insurance Coverage Protection Commission to require a study on individual and group health insurance market stability

Requires an actuarial analysis comparing Medicaid and commercial rates to estimate potential premium savings from a public option

Directs exploration of regulatory exemptions for managed care organizations, merging individual and small group markets, and interstate pooling of purchasing power

Requires consideration of prescription drug cost controls including a state pharmacy benefit administrator, ways to sustain federally qualified health centers, and a multiyear reinsurance stability fund

Takes effect July 1, 2026 and remains effective until the termination of the underlying Health Insurance Coverage Protection Commission established by Chapter 696 of the Acts of 2025